Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Baylor Scott & White Research Institute
Headquarters: Dallas, TX, United States of America
Website: http://www.baylorhealth.edu...
Year Founded: 1984
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Nov 7, 2024
Management Tracks
Celltex names Anita Perry CEO
Plus: Arnav Mehta joins The Column Group as venture partner and an update from Acumen
BioCentury | Oct 17, 2024
Discovery & Translation
‘Learning labs’ aim to advance learning health system
Highlander Institute, headed by former Verily executives, announces first grants
BioCentury | Aug 25, 2023
Product Development
Grail partnership latest step for broader access to multicancer tests
Study to evaluate community outreach strategies for increasing early cancer screening in diverse populations, follows similar deal by Exact Sciences in June
BioCentury | Dec 5, 2020
Management Tracks
CureVac hires GSK Vaccines veteran Blanc as CBO and chief commercial officer; plus moves at Spero, 4D, Transgene, Achilles and Datavant
mRNA play CureVac N.V. (NASDAQ:CVAC) hired Antony Blanc as CBO and chief commercial officer. Blanc most recently was managing director at Clarentis s.r.l., and prior to that VP, global
BioCentury | Jan 25, 2020
Product Development
The race is on to develop therapies and vaccines for the coronavirus outbreak
The coronavirus outbreak is creating a testbed for new vaccine and therapeutic technologies
BioCentury | Sep 29, 2017
Regulation
Beyond compassion
The case for using expanded access protocols to generate real world data
BioCentury | Feb 24, 2017
Product Development
Dendritic cell control
How Denceptor is targeting dendritic cells to fine tune T cell responses
Items per page:
1 - 10 of 12